Home/Filings/4/0001236215-21-000015
4//SEC Filing

CIPRIANO JOHN 4

Accession 0001236215-21-000015

CIK 0000725363other

Filed

Nov 28, 7:00 PM ET

Accepted

Nov 29, 9:33 AM ET

Size

5.6 KB

Accession

0001236215-21-000015

Insider Transaction Report

Form 4
Period: 2021-11-19
CIPRIANO JOHN
Senior Vice President
Transactions
  • Award

    Options

    2021-11-19$0.01/sh+50,000$500788,827 total
    Exercise: $10.48Exp: 2031-11-18Common Stock (50,000 underlying)
Footnotes (1)
  • [F1]Each option entitles the holder to purchase one share of the Company's common stock at a price of $10.48 per share. The stock options vest 100% upon the approval of the first marketing application for any pharmaceutical based upon the Company's Multikine technology in any of the USA, Canada, UK, Germany, France, Italy, Spain, Japan, or Australia. None of the options will be exercisable before November 19, 2022.

Issuer

CEL SCI CORP

CIK 0000725363

Entity typeother

Related Parties

1
  • filerCIK 0001282304

Filing Metadata

Form type
4
Filed
Nov 28, 7:00 PM ET
Accepted
Nov 29, 9:33 AM ET
Size
5.6 KB